Free Trial

HealthEquity (HQY) Stock Price, News & Analysis

HealthEquity logo
$100.69 -0.59 (-0.58%)
As of 10:34 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About HealthEquity Stock (NASDAQ:HQY)

Key Stats

Today's Range
$99.90
$102.17
50-Day Range
$84.40
$113.06
52-Week Range
$65.01
$116.65
Volume
113,287 shs
Average Volume
857,476 shs
Market Capitalization
$8.71 billion
P/E Ratio
73.60
Dividend Yield
N/A
Price Target
$118.09
Consensus Rating
Buy

Company Overview

HealthEquity Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
73rd Percentile Overall Score

HQY MarketRank™: 

HealthEquity scored higher than 73% of companies evaluated by MarketBeat, and ranked 299th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    HealthEquity has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 9 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    HealthEquity has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about HealthEquity's stock forecast and price target.
  • Earnings Growth

    Earnings for HealthEquity are expected to grow by 22.41% in the coming year, from $2.32 to $2.84 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of HealthEquity is 73.60, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.50.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of HealthEquity is 73.60, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.57.

  • Price to Earnings Growth Ratio

    HealthEquity has a PEG Ratio of 1.58. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    HealthEquity has a P/B Ratio of 4.10. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about HealthEquity's valuation and earnings.
  • Percentage of Shares Shorted

    6.18% of the float of HealthEquity has been sold short.
  • Short Interest Ratio / Days to Cover

    HealthEquity has a short interest ratio ("days to cover") of 4.6.
  • Change versus previous month

    Short interest in HealthEquity has recently decreased by 11.74%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    HealthEquity does not currently pay a dividend.

  • Dividend Growth

    HealthEquity does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.18% of the float of HealthEquity has been sold short.
  • Short Interest Ratio / Days to Cover

    HealthEquity has a short interest ratio ("days to cover") of 4.6.
  • Change versus previous month

    Short interest in HealthEquity has recently decreased by 11.74%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    HealthEquity has a news sentiment score of 0.98. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 16 news articles for HealthEquity this week, compared to 11 articles on an average week.
  • Search Interest

    Only 2 people have searched for HQY on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added HealthEquity to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, HealthEquity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $33,664,018.00 in company stock.

  • Percentage Held by Insiders

    Only 1.50% of the stock of HealthEquity is held by insiders.

  • Percentage Held by Institutions

    99.55% of the stock of HealthEquity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about HealthEquity's insider trading history.
Receive HQY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HealthEquity and its competitors with MarketBeat's FREE daily newsletter.

HQY Stock News Headlines

How to Collect Up To $5,917/mo From Trump’s Made In USA Boom
How to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First policies, a historic wave of investment is flooding back into the United States: Apple committing a colossal $500 billion to build new U.S. factories. Microsoft injecting $80 billion into domestic manufacturing. Nvidia moving critical chip production back to America. But here's the hidden opportunity: There's now a groundbreaking way for you to start collecting monthly checks from these very same companies— checks that could reach as high as $5,917 each month. Don't miss your chance to participate directly in America's industrial comeback.
Zacks Research Has Positive View of HealthEquity Q2 Earnings
Zacks Research Has Weak Outlook for HealthEquity Q3 Earnings
See More Headlines

HQY Stock Analysis - Frequently Asked Questions

HealthEquity's stock was trading at $95.95 at the beginning of 2025. Since then, HQY shares have increased by 4.9% and is now trading at $100.69.
View the best growth stocks for 2025 here
.

HealthEquity, Inc. (NASDAQ:HQY) issued its quarterly earnings results on Tuesday, June, 3rd. The company reported $0.97 EPS for the quarter, topping analysts' consensus estimates of $0.81 by $0.16. The firm earned $330.80 million during the quarter, compared to analyst estimates of $322.25 million. HealthEquity had a trailing twelve-month return on equity of 11.01% and a net margin of 9.80%.
Read the conference call transcript
.

Shares of HQY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that HealthEquity investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Netflix (NFLX), Palo Alto Networks (PANW) and Adobe (ADBE).

Company Calendar

Last Earnings
6/03/2025
Today
7/03/2025
Next Earnings (Estimated)
9/02/2025
Fiscal Year End
1/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Business Services
Current Symbol
NASDAQ:HQY
Employees
3,120
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$118.09
High Stock Price Target
$130.00
Low Stock Price Target
$100.00
Potential Upside/Downside
+16.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
11 Analysts

Profitability

Trailing P/E Ratio
73.93
Forward P/E Ratio
43.66
P/E Growth
1.58
Net Income
$96.70 million
Pretax Margin
12.37%

Debt

Sales & Book Value

Annual Sales
$1.20 billion
Cash Flow
$4.20 per share
Price / Cash Flow
24.13
Book Value
$24.56 per share
Price / Book
4.12

Miscellaneous

Free Float
85,178,000
Market Cap
$8.76 billion
Optionable
Optionable
Beta
0.49

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:HQY) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners